A young man functionally cured of sickle cell disease — and the cure is reaching children

Published · Researched 2026-09-22

What happened (dated facts)

Daniel Cressy, 23, of Metairie, Louisiana, became the first person in Louisiana and the Gulf South to be functionally cured of sickle cell disease. His stem cells were collected in late 2025 (collection began July 30, 2025), shipped to Scotland for CRISPR editing with Casgevy (exagamglogene autotemcel), and returned in March 2026; after chemotherapy to clear his diseased cells, the edited cells were infused on March 18, 2026, at Manning Family Children's Hospital in New Orleans. Discharged in mid-April, his hemoglobin is now the highest it has ever been, he has had no sickle cell crises since treatment, and he is working toward a first-class medical clearance to pursue his dream of becoming a pilot. The $2.2 million drug cost was covered by Louisiana Medicaid after a two-year approval process. Separately, on July 1, 2026, the FDA expanded Casgevy's approval to children aged 2 to 11 with sickle cell disease and recurrent vaso-occlusive crises — the first CRISPR-based therapy approved for young children with the disease.

Why it is genuinely positive

Sickle cell disease means a lifetime of excruciating pain crises, organ damage, and shortened life for ~100,000 Americans. A one-time treatment that functionally cures it — and is now approved for toddlers — converts a life sentence into a solved problem for eligible patients. One young man is about to fly planes because of it.

Social pulse

Sickle cell community discussion on Threads: virgo.goddess (Larenza, living with SCD for 3.5+ decades, Sept 22, 2026) posting about her own opportunity for gene therapy and "a REAL life"; biotech roundup account biomeetsai (Aug 21, 2026) listing Cressy's cure among the week's biotech highlights; dr.akash_parashar5 (Sept 19, 2026) on WHO's first dedicated SCD guideline for children and adolescents. Local news coverage (nolanewswire, urbangeekz) with the hospital's official announcement as the anchor.

Verified quotes

• "This is a proud and transformational moment for all of us." — Manning Family Children's Hospital announcement, via nolanewswire, June 2026 (hospital's framing of Cressy's treatment).
• None of Cressy's own words were independently verified this session; no patient quotes are invented here.

Verification

• Tier: 2
• Primary source: Manning Family Children's Hospital official announcement (via nolanewswire, June 2026; urbangeekz, June 2026; medicaldaily). Proves: patient identity, treatment timeline, infusion date (March 18, 2026), functional-cure outcome, Medicaid coverage. FDA pediatric expansion (July 1, 2026) via Vertex announcement covered in Optum clinical update and The Life Science Feed.
• Social sources: Threads — virgo.goddess (Sept 22, 2026, SCD patient pursuing gene therapy); biomeetsai (Aug 21, 2026, Cressy cure in biotech roundup). Proves: the cure story is circulating in patient and biotech communities, not just press releases.
• Positivity check: a real patient, cured, with hospital confirmation and a name — plus a pediatric label expansion that widens access. Passed.

Key facts

UNVERIFIED points

• WHO's first dedicated SCD guideline for children/adolescents (2026) observed only via a Threads post — not verified against WHO this session.
• Pediatric trial efficacy denominators conflict across secondary sources (16/18 vs 8/8 VOC-free in different summaries) — the expansion fact is verified; the exact subgroup numbers are not.
• No direct quotes from Cressy himself were verified; hospital/third-party framing only.